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How Did Disinfection Become a
Widely-used HIV Prevention
Strategy?
The strategy of disinfecting syringes to
prevent HIVemerged in California in
the 1980s. East Coast epidemics
among IDUs (especially in New York)
made public health officials fear that
HIV would be a major threat to
California IDUs. 
California IDUs, like those in other
parts of the country, shared and reused
syringes, in part because it was hard for
them to get new, sterile ones. This
greatly increased their risk of HIV
transmission (see box, page 2). State
law made it illegal for drug users to
buy syringes from pharmacies and a
crime to possess them. Restricted
access to sterile syringes, combined
with limited capacity of substance
abuse treatment programs, forced pre-
vention programs to focus on reducing
injection-related risks among IDUs
who would not or could not stop
injecting. Field research in California
showed that IDUs would act to reduce
their risks if acceptable measures were
available to them. One such measure
was syringe disinfection with household
bleach. (Disinfection means using
something to kill viruses and bacteria
that cause infection.) Laboratory tests
had shown that bleach killed HIV.
Bleach also was cheap, quick, and avail-
able everywhere.
This led community programs to train
outreach workers to teach IDUs how
they could reduce the risk of infection
by disinfecting their syringes and needles. 
Distribution of bleach kits — small
(usually 1-oz. size) bottles of full-
strength household bleach with instruc-
tions on how to disinfect syringes —
quickly became a standard component
of IDU prevention in San Francisco.
Other U.S. cities then rapidly adopted
this strategy. 
How Disinfection Can Reduce
Transmission Risk: It Reduces
the Number of Viruses and It
Kills Them
Current disinfection recommendations
are based on the following steps:
• Flush out blood, drugs, and other
organic matter from the syringe. These
can contain viruses and do interfere
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For 20 years, syringe disinfection has been a part of HIV prevention efforts for injection drug users
(IDUs). Questions about it persist, however, because of limited scientific studies, varying recommendations
on the right way to disinfect, and evidence suggesting that IDUs do not use this approach very much. This 
fact sheet presents basic information on disinfection, especially bleach disinfection. The central message is that 
disinfection is a back-up prevention strategy if the user cannot stop injecting; does not have a new, sterile
syringe; and is about to inject with a syringe that has been used before. 
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Substance abuse treatment and access
to sterile syringes through pharmacies,
physician prescription, and syringe
exchange programs are essential com-
ponents of HIV prevention efforts
among injection drug users. See “To
Learn More About This Topic” at the
end of this fact sheet for information
on how to get fact sheets on these
topics as well as other materials on
HIV prevention among IDUs.
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• Disinfect the syringe.
• Rinse out the disinfectant.
The idea behind these steps is to reduce
the risk of HIV transmission in two
ways. First, flushing removes blood and
drugs from the syringe, which reduces
the number of viral particles. Second,
using a disinfectant can kill remaining
viruses so they can’t infect anyone else.
Instructions for disinfecting syringes
usually include ways to make sure that
viruses are removed and killed:
• Fill the syringe with clean water (such
as water right from a tap or a new
bottle of water). 
• Shake or tap the syringe containing
water or disinfectant (this dislodges 
particles and thoroughly mixes the
water or disinfectant with material in
the syringe); then squirt out and
throw away the water; repeat until no
more blood can be seen.
• Leave the water or disinfectant, espe-
cially the disinfectant, in the syringe
for a while (in principle, the longer
the better; for example, 30 seconds is
better than 15 seconds); then squirt
out the disinfectant.
• Rinse out the syringe with clean
water (fill syringe, shake or tap, squirt
out and throw away water); rinsing is
done to get rid of disinfectant and
any viruses left in the syringe.
Does Disinfection Work Against
Viral Hepatitis?
Hepatitis B virus (HBV) and hepatitis
C virus (HCV) cause serious illness
among millions of people. They also are
closely connected with HIV, injection
drug use, and high-risk sexual behaviors.
Many people think that disinfection
doesn’t work against HBV or HCV, but
laboratory studies on HBV show that
disinfection works against this blood-
borne virus in the same ways that it
does against HIV. 
An important thing to remember about
HBV and HCV is that the numbers of
viruses in blood are much higher for
HBV and HCV than they are for HIV.
As a result, getting rid of as much
blood as possible by flushing out and
rinsing is especially important in reduc-
ing the risk of becoming infected with
viral hepatitis. 
Disinfection Seems to Make
Sense. What’s the Problem?
A Disinfected Syringe is NOT a Sterile
Syringe
If it is done carefully and thoroughly,
disinfection can reduce the amount of
live HIV, HBV, and HCV in a syringe.
However, even the best disinfection pro-
cedure cannot guarantee that all viruses
have been killed.  The plastic syringes
usually used by IDUs are designed for
one-time use.  They are not designed to
be cleaned and used again.
Disinfected syringes do NOT meet the
standards that are applied in all other
settings in which people use syringes
(such as hospitals, other health care set-
tings, and insulin injections by people
with diabetes). In these settings, people
must use a new, sterile syringe for every
injection.
For these reasons, a disinfected syringe
is NOT as safe as a new, sterile syringe.
Recommendations about disinfecting
The Link Between Preparing Injection Drugs and the 
Risk of Transmission 
The drugs used by IDUs (heroin, cocaine, amphetamines) usually are sold as a powder
that must be dissolved in water before they can be injected. Some injection drugs, such
as black-tar heroin, which is a gummy solid not a powder, must be heated in a spoon or
bottle cap (a “cooker”) to speed up the dissolving. Once dissolved, the drug is drawn
into a syringe through a filter (a “cotton”) that prevents small particles in the solution
from clogging the needle. The drug is then injected into a vein. Sometimes, two or more
IDUs will draw up drugs from the same cooker.
Before injecting, a user must be sure that the needle is in a vein. He or she does this by
pulling back on the plunger after pushing the needle through the skin in a likely spot.
Blood entering the syringe (“registering”) shows that the needle is in a vein. Once the
drug has been injected, the IDU may pull back the plunger, drawing blood back into the
syringe, and then re-inject it into the vein (“booting” or “jacking”). After injecting, the
user rinses out the syringe with water to prevent any remaining blood from clogging the
needle. Users often dissolve drug powder and rinse their syringes with water from the
same container.
HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) can be transmitted when IDUs
share the same syringe. These viruses also can be transmitted when users divide drug
solution among several syringes, share rinse water or a cotton or cooker, or mix the
drug solution with a used syringe. Transmission can occur when any element — syringe,
water, cotton, cooker, drug solution — becomes contaminated with blood that is infect-
ed with HIV, HBV, or HCV because that element can contaminate any other element it
touches. Even if an IDU is careful to always use a new, sterile syringe to inject drugs, the
process of sharing contaminated equipment, drug solution, or water can
increase his or her risk of acquiring or transmitting HIV, HBV, or HCV. (For more infor-
mation about drug preparation and viral transmission, see Koester, 1998.)
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syringes with bleach or others agents
apply ONLY to situations in which
IDUs do not have sterile syringes.
Scientists Have Limited Laboratory Evidence
that Disinfection Works Against HIV in
Syringes and Other Injection Equipment 
Scientists have published a small num-
ber of laboratory studies on the ability
of bleach and other agents to kill HIV.
These experiments try to mimic condi-
tions faced by IDUs and usually test the
impact of disinfection on blood to
which HIV grown in a test tube has
been added. 
However, these conditions are not the
same as those faced by IDUs, and find-
ings are not definitive. In laboratory
studies, fresh undiluted household bleach
(5.25% sodium hypochlorite) appears to
kill HIV pretty well. Scientists also have
tested whether other liquids can disinfect
syringes. These liquids, which are some-
times used by IDUs, include dish deter-
gent, rubbing alcohol, hydrogen peroxide,
and fortified wine. Results of these few
studies are limited. 
Some research has found that even sev-
eral vigorous rinses with clean water
may be as effective as undiluted house-
hold bleach because they do a good job
of reducing the number of infectious
viruses. 
Results of these studies depend on
many things, including the strength of
the agent, whether the HIV is in whole
blood or by itself, and the steps used.
Because few laboratory studies have
been published, we have only limited
data on disinfection as it is done by
IDUs. As a result, we don’t have clear
answers to questions about which agents
work best, the best disinfection proce-
dures, or the time necessary for ade-
quate disinfection. 
Laboratory studies of the effect of dis-
infection on HBV and HCV are diffi-
cult because these viruses cannot be
grown in a test tube. Studies with ani-
mals have shown that disinfection can
prevent HBV transmission. Because
HBV and HCV are similar, these find-
ings may also be true for HCV.
However, it’s important to note that
conditions in animal studies are not the
same as those faced by IDUs.
Studies of IDUs Do Not Prove That Bleach
Disinfection Protects them Against HIV or
Viral Hepatitis
Studies have looked for differences in
the number of new infections between
injectors who say they always disinfect
and injectors who say they do not dis-
infect. They have found no significant
difference in new infections among
IDUs in the two groups. Several factors
may help explain these findings.
• Studies don’t measure risk behaviors
completely. Studies don’t always col-
lect detailed risk information and may
focus only on an IDU’s risky drug
practices. As a result, a study focusing
on disinfection may not show any-
thing if the infection is due to some-
thing else, such as having unprotected
sex with infected partners. 
• Some studies have technical limita-
tions. For example, sometimes it is
hard for a scientist to know whether a
person is really a “disinfector” or a
“non-disinfector.” IDUs in the study
may not remember correctly whether
or how many times they used bleach
during a certain period in the past.
Or, they may think that saying they
used bleach is the answer the scien-
tists want to hear. As a result, IDUs
who say they disinfect may seem to
be at the same risk of infection as
those who say they don’t disinfect. 
Barriers Make it Hard for IDUs to
Disinfect Correctly and Can Prevent Them
from Doing It At All
IDUs may agree that disinfection is a
good idea if they cannot get new, sterile
syringes. However, some investigators
have found that few IDUs actually use
bleach to disinfect syringes or they don’t
go through all the recommended steps
if they do use it. Many factors make it
hard for IDUs to disinfect: 
• Current instructions involve a lot of
steps and IDUs may think it is
impossible to do correctly.
• IDUs may not be able to get clean
water. 
• They may not want to carry bleach or
other disinfectants because it marks
them as drug users. 
Bleach has Advantages
and Disadvantages as a
Disinfectant
Advantages:
• It can reduce the amount of infec-
tious HIV, HBV, and HCV in a used
syringe.
• It is readily available. 
• It is inexpensive.
Disadvantages:
• IDUs, outreach workers, and 
policymakers may mistakenly
believe that disinfecting with
bleach is as safe as using a new,
sterile syringe.
• It does not sterilize the syringe, so
the syringe may still carry infec-
tious organisms after disinfection.
• Studies have not shown that
bleach disinfection prevents HIV
or HCV transmission among IDUs.
• If a person carries small bottles of
bleach, police may assume he or
she is a drug user. 
• Sunlight, warm temperatures, and
exposure to air gradually weaken
bleach so that it doesn’t work
anymore; IDUs have to be sure to
use fresh, full-strength bleach.
• It damages the syringe. 
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• Withdrawal symptoms (being “drug
sick”) and the overpowering need to
inject as soon as possible also may drive
an IDU to inject without disinfecting. 
• Some IDUs need help to inject and
other people give them the injection.
The person doing the injecting may
not disinfect thoroughly. 
• Drug users may not have time to dis-
infect carefully because they must pre-
pare the drug solution and inject quick-
ly (for example, police are nearby). 
• Once the IDU has injected, the
effects of the drug may prevent him
or her from disinfecting carefully
before the next injection (this may be
especially true with cocaine, which is
commonly injected multiple times in
a drug use session). 
What are the Take-Home
Messages? 
• The way that an IDU prepares and
injects drugs is important in deter-
mining the risk of that person get-
ting or transmitting HIV, HBV, and
HCV: 
Any item — syringe, water, drug
solution, cooker, cotton — that is
contaminated with blood contain-
ing these viruses can contaminate
all the other items. 
Even if an IDU uses a sterile
syringe each time, he or she can
become infected if the drug solu-
tion or preparation equipment is
shared with others who are infected. 
• Disinfection will not make injecting
drugs “safe.” It may make injecting 
“less risky” because it can reduce the
number of and kill some of the HIV,
HBV, or HCV in a syringe. As a
result, disinfection can be a useful
back-up strategy for IDUs. 
• We don’t have clear, consistent labo-
ratory evidence about the best disin-
fection procedure and we don’t know
how effective this strategy is. So, we
suggest steps that seem logical.
• Disinfection should be used only
when an IDU has no safe options
for preventing transmission. 
Disinfection is not as good as stop-
ping injecting, getting into sub-
stance abuse treatment, using a new
sterile syringe, and not sharing drug
solution and equipment. 
Bleach and other disinfectants do
NOT sterilize the syringe.
What Should We Tell IDUs?
Education and outreach workers should
stress the following messages when they
talk to IDUs:
• The best way for you to prevent HIV,
HBV, and HCV transmission is to
NOT inject drugs.
• Entering substance abuse treatment
can help you reduce or stop injecting.
This will lower your chances of infec-
tion.
• Get vaccinated against hepatitis A
and hepatitis B. You can prevent these
kinds of viral hepatitis if you get vac-
cinated.
• If you cannot or will not stop inject-
ing, you should:
Use a new, sterile syringe obtained
from a reliable source to prepare
and divide drugs for each injection.
Never reuse or share syringes,
water, cookers, or cottons.
Use sterile water to prepare drugs
each time, or at least clean water
from a reliable source.
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Keeping Everything Clean is an Important Part of
Reducing HIV and Viral Hepatitis Risk
More and more, health workers are realizing that cleanliness and good hygiene can help
reduce an IDU’s risk of getting or transmitting HIV or viral hepatitis. Good hygiene can
also help prevent sores and bacterial infections in the skin where IDUs inject. The fol-
lowing tips are an important part of the prevention message to IDUs who cannot or will
not stop injecting:
• Wash your hands and arms before preparing to inject.
• Use a clean surface to prepare drugs for injection, or spread out a piece of clean
paper.
• Use an alcohol pad to clean the skin where you’re going to inject.
• After injecting, use a gauze pad to stop the bleeding.
• Put a bandage on the place where you injected.
• Throw away the used alcohol pad and gauze and all the other drug preparation
equipment.
• Clean anything else blood might have touched (such as the tourniquet, your inject-
ing space, or your clothes). 
• Safely dispose of the syringe.
• Wash your hands again to clean off dirt, blood, and viruses.
Sources: Marcia Bisgyer of SafetyWorks, Inc., Mamaroneck NY, and Allen Clear of Harm
Reduction Coalition, New York, NY (www.harmreduction.org)
4
5
Keep everything as clean as possible
when injecting (see box, left).
• If you can’t use a new, sterile syringe
and clean equipment each time, then
disinfecting with bleach may be better
than doing nothing at all:  
Fill the syringe with clean water
and shake or tap. Squirt out the
water and throw it away. Repeat
until you don’t see any blood in the
syringe.
Completely fill the syringe with
fresh, full-strength household
bleach. Keep it in the syringe for 30
seconds or more. Squirt it out and
throw the bleach away. 
Fill the syringe with clean water
and shake or tap. Squirt out the
water and throw it away.
• If you don’t have any bleach, use clean
water to vigorously flush out the
syringe:
Fill the syringe with water and
shake or tap it. Squirt out the water
and throw it away. 
Do this several times.
To Learn More about This Topic
Visit websites of the Centers for 
Disease Control and Prevention
(www.cdc.gov/idu) and the Academy
for Educational Development
(www.healthstrategies.org/pubs/
publications.htm) for these and related
materials: 
• Preventing Blood-borne Infections Among
Injection Drug Users: A Comprehensive 
Approach, which provides extensive
background information on HIV and
viral hepatitis infection in IDUs and
the legal, social, and policy environ-
ment, and describes strategies and
principles of a comprehensive
approach to addressing these issues.
• Interventions to Increase IDUs’ Access to
Sterile Syringes, a series of six fact
sheets.
• Drug Use, HIV, and the Criminal Justice
System, a series of eight fact sheets.
• Substance Abuse Treatment and Injection
Drug Users, a series of six fact sheets.
• Viral Hepatitis and Injection Drug Users, 
a series of five fact sheets.
Small numbers of these publications
can be ordered at no charge from
www.cdc.gov/idu.
See the July 1994 issue of the Journal
of Acquired Immune Deficiency Syndromes.
This issue of the Journal includes seven
papers from a workshop on the use of
bleach to disinfect drug injection equip-
ment. The papers provide an historical
perspective on the use of bleach in
HIV/AIDS prevention activities, review
results of laboratory studies on the
effectiveness of various agents in inacti-
vating HIV, and describe the results of
field studies on the disinfection prac-
tices of IDUs. (Journal of Acquired Immune
Deficiency Syndromes 1994;7(7):741-776.)
See the April 1993 CDC/CSAT/NIDA
HIV/AIDS Prevention Bulletin. This
publication reviews the topic of disin-
fection and concludes that stopping
injection or using new, sterile syringes
is superior to disinfection. (Curran JC,
Scheckel LW , Millstein RA.
HIV/AIDS prevention bulletin.
Centers for Disease Control, Center for
Substance Abuse Treatment, and
National Institute on Drug Abuse,
April 19, 1993.) www.cdc.gov/idu/
pubs/bleach_letter.htm
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Bourgois P. Anthropology and epidemi-
ology on drugs: the challenges of cross-
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logue. The International Journal of Drug
Policy 2002;13(4):259-269.
Centers for Disease Control and
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chronic disease. Morbidity and Mortality
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www.cdc.gov/mmwr/preview/
mmwrhtml/00055154.htm
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Disinfection should be used
ONLY when an IDU has no safe
options for preventing 
transmission. 
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